IBS imposes a substantial burden on patients, families, and healthcare systems in South Korea. Understanding this burden helps policymakers, providers, and manufacturers appreciate the need for better diagnosis, treatment, and support.

The clinical burden includes chronic pain, bloating, and unpredictable bowel habits that disrupt daily life. The economic burden includes direct costs of medications, consultations, and procedures, and indirect costs such as lost productivity and absenteeism. The personal burden includes anxiety, depression, and social limitations. These burdens are significant and often underestimated, as reflected in the South Korea Irritable Bowel Syndrome Treatment Market report.

Addressing the burden requires earlier diagnosis, better treatment options, and greater awareness. Public education, clinical guidelines, and support services can contribute. For patients, understanding the condition and adhering to treatment improves outcomes. For providers, personalised care and patient education are essential. As South Korea's healthcare system continues to prioritise digestive health, the burden of IBS can be reduced.

People Also Ask

Why is IBS often underdiagnosed?
Symptoms overlap with other conditions, and patients may be reluctant to seek help due to stigma or embarrassment.

How does IBS affect quality of life?
It can cause chronic discomfort, anxiety, social limitations, and reduced productivity.

Tags: #IBS #DiseaseBurden #SouthKorea #Gastroenterology #PublicHealth #PatientCare